Neodyne Biosciences Reports Published Favorable Results of a...

... trial of the embraceA device (REFINE) are scheduled to be presented at the American Society for Aesthetic Plastic Surgery Meeting, Neodyne's first product, embraceA Advanced Scar Therapy, received 510(k) clearance from the US Food and Drug ...

http://ift.tt/1jNKSkH